TY - JOUR T1 - Generating the evidence for risk reduction: a contribution to the future of food-based dietary guidelines. JF - Proc Nutr Soc Y1 - 2018 A1 - Lukas Schwingshackl A1 - Sabrina Schlesinger A1 - Brecht Devleesschauwer A1 - Georg Hoffmann A1 - Angela Bechthold A1 - Carolina Schwedhelm A1 - Khalid Iqbal A1 - Sven Knüppel A1 - Heiner Boeing KW - evidence KW - Food-based dietary guidelines KW - meta-analysis AB -

A major advantage of analyses on the food group level is that the results are better interpretable compared with nutrients or complex dietary patterns. Such results are also easier to transfer into recommendations on primary prevention of non-communicable diseases. As a consequence, food-based dietary guidelines (FBDG) are now the preferred approach to guide the population regarding their dietary habits. However, such guidelines should be based on a high grade of evidence as requested in many other areas of public health practice. The most straightforward approach to generate evidence is meta-analysing published data based on a careful definition of the research question. Explicit definitions of study questions should include participants, interventions/exposure, comparisons, outcomes and study design. Such type of meta-analyses should not only focus on categorical comparisons, but also on linear and non-linear dose-response associations. Risk of bias of the individual studies of the meta-analysis should be assessed, rated and the overall credibility of the results scored (e.g. using NutriGrade). Tools such as a measurement tool to assess systematic reviews or ROBIS are available to evaluate the methodological quality/risk of bias of meta-analyses. To further evaluate the complete picture of evidence, we propose conducting network meta-analyses (NMA) of intervention trials, mostly on intermediate disease markers. To rank food groups according to their impact, disability-adjusted life years can be used for the various clinical outcomes and the overall results can be compared across the food groups. For future FBDG, we recommend to implement evidence from pairwise and NMA and to quantify the health impact of diet-disease relationships.

VL - 77 CP - 4 M3 - 10.1017/S0029665118000125 ER -